(PDFs) have been shown to damage the mesothelial layer and are associated with the development of peritoneal fibrosis and neoangiogenesis. New-generation PDFs have therefore been developed with physiological pH and reduced levels of glucose degradation products (GDPs), precursors of advanced glycation end products (AGEs). In this work, we evaluated and compared the improved biocompatibility of two new-generation PDFs (Balance and bicaVera) using mesothelial cell biology; we also compared them to a standard PDF (stay·safe) (all PDFs by Fresenius Medical Care, Fresnes, France). ♦♦ ♦♦ ♦ Methods: stay·safe, Balance, and bicaVera were tested for their effect on human peritoneal mesothelial cell (HPMC) viability by measuring cell proliferation and apoptosis, and oncosis induction. The formation of AGEs was evaluated by immunoassay. Transforming growth factor beta-1 and vascular endothelial growth factor (VEGF) were immunoassayed in HPMC supernatants exposed to the above PDFs. ♦♦ ♦♦ ♦ Results: At 15 g/L glucose concentration, HPMC exposure to bicaVera resulted in higher cell proliferation compared to Balance (p < 0.001) and stay·safe (p < 0.001). Compared to the lactate-buffered PDFs (Balance and stay·safe), oncosis was significantly lower in cells exposed to bicaVera (p < 0.05). bicaVera, containing lower amounts of GDPs, generated less AGE formation (p < 0.05) and VEGF production (p < 0.05) than either Balance or stay·safe. ♦♦ ♦♦ ♦ Conclusions: New-generation PDFs with physiological pH and lower GDP levels, especially if bicarbonate-buffered (bicaVera), have fewer in vitro toxic effects on mesothelial cells and may contribute to peritoneal preservation, thus improving long-term treatment of PD patients. P rogressive functional and structural degenerative peritoneal alterations are major factors leading to treatment failure in peritoneal dialysis (PD) patients. Peritoneal membrane alterations, such as fibrosis and neoangiogenesis, are associated with loss of ultrafiltration (1, 2) . Peritoneal exposure to conventional poorly biocompatible PD fluids (PDFs) that combine nonphysiological pH, high glucose concentrations, and high levels of glucose degradation products (GDPs) -generated during heat sterilization -is a source of treatment failure (3). New-generation PDFs with improved biocompatibility (neutral pH, low GDP content) have therefore been developed for the long-term treatment of PD patients.
Separation of glucose during heat sterilization limits the formation of GDPs known to be precursors of advanced glycation end products (AGEs) (4) . It has been proposed that direct GDP-induced PDF toxicity may be largely mediated by 3,4-dideoxyglucosone-3-ene (3,4-DGE) present in PDFs during the early period after heat sterilization (5-7). In addition, we previously demonstrated the in vitro synergistic deleterious effects of glucose, GDPs, such as 3-deoxyglucosone (3-DG), and AGEs on peritoneal mesothelial cell viability (8) . AGEs such as N ε -(carboxymethyl)lysine (CML), the highest affinity ligand for RAGE (receptor for AGEs), have also been described as being mesothelial cell activators (9) . In a recent pilot study, we demonstrated that PD initiation is associated with an increase in blood levels of AGEs, particularly in diabetic patients, but is also associated with a decrease in oxidative products such as advanced oxidation protein products , especially in nondiabetic subjects (10) .
The present in vitro study compared the effects of a new-generation biocompatible bicarbonate-buffered PDF (bicaVera) to those of two lactate-buffered PDFs, one a new-generation biocompatible lactate-buffered PDF (Balance) and the second a conventional PDF (stay·safe), on human peritoneal mesothelial cell (HPMC) biology. The effects of these three PDFs were assessed on cell viability, formation of AGEs, and production of transforming growth factor beta-1 (TGF-β1) and vascular endothelial growth factor (VEGF), two major growth factors that promote the development of fibrosis and neoangiogenesis respectively. In addition, the stability of bicaVera over time was also examined using the same methods of in vitro biocompatibility assessment.
MATERIALS AND METHODS

PERITONEAL DIALYSIS FLUIDS
All the PDFs were provided by Fresenius Medical Care (Fresnes, France). One conventional and two new-generation PDFs were investigated in this study at two different glucose concentrations (15 and 42.5 g/L glucose): a lactate-buffered PDF (stay·safe), a lactate-buffered two-compartment bag PDF (Balance), and a bicarbonate-buffered two-compartment bag PDF (bicaVera). Glucose separation was carried out for Balance and bicaVera to reduce GDP formation (pH 3) during heat sterilization. Composition and respective GDP levels of each PDF are shown in Table 1 (11) . In order to determine stability of the bicaVera solution over time, viability assessment and AGE formation experiments were carried out using the latter PDF just after production (T0), then 12 and 24 months after production (T12 and T24).
CELL CULTURE
The HPMCs were isolated from freshly obtained omental tissue from patients who had undergone elective abdominal surgery. Subjects with diabetes mellitus, abdominal inflammation, or diffuse carcinoma were excluded from the study, which was conducted in accordance with the guidelines laid down in the revised Tokyo version of the Declaration of Helsinki, and with the rules of our institution. HPMCs were grown in M199 solution supplemented with 20% fetal calf serum (Dutscher, Brumath, France) and 5 µg/mL endothelial cell growth factor (Sigma, St. Louis, Missouri, USA) (9). Cells were characterized by their morphological appearance and by flow cytometry analysis. Immediately prior to and at confluence, cells adopted the polygonal cobblestone appearance characteristic of epithelial cells and formed a monolayer. HPMCs expressed the mesothelial marker cytokeratin-18, and failed to express the endothelial marker, PECAM-1 (CD31). RAGE expression on HPMC membrane has been described previously (9) .
CELL PROLIFERATION ASSAY
Cell proliferation was examined by measuring the incorporation of [methyl-3 H]thymidine (Amersham Pharmacia Biotech, Bucks, United Kingdom) into acidinsoluble DNA of cultured HPMCs (8) . HPMCs were seeded at 15 × 10 3 cells/well in 96-well plates for 24 hours, then incubated for 24 hours with stay·safe, Balance, or bicaVera PDF mixed with culture medium (1/1 ratio), and finally pulsed with methyl-[ 3 H]thymidine (1 µCi/well). Results are expressed as counts per minute (cpm).
APOPTOSIS AND ONCOSIS
Programmed (apoptosis) and disorganized (oncosis) cell deaths were studied. Apoptosis was evaluated by flow cytometry using the potential-sensitive dye 3,3'-dihexyloxacarbocyanine iodide [DiOC 6 -(3)], which accumulates in the mitochondria of living cells (Molecular Probes, Eugene, Oregon, USA). Oncosis was investigated by measuring propidium iodide (PI) DNA-intercalating capacity (8) .
After incubation with a PDF/culture medium mixture (1/1 ratio), adherent cells were treated with trypsinethylene diamine tetraacetic acid (EDTA) for 4 minutes at 37°C. Cells were then washed and stained with DiOC 6 -(3) (80 nmol/L) and PI (15 µg/mL), and left for 30 minutes at 37°C in the dark. DiOC 6 -(3) and PI fluorescence was measured by FACScan (Becton Dickinson, Mountain View, California, USA). Results are expressed in terms of the percentage of apoptotic or oncotic cells.
TOTAL AGE-PROTEIN AND CML IMMUNOASSAY
Generation of AGEs induced by incubating PDFs for 7 days at 37°C with culture medium (1/1 ratio) containing human albumin (10 g/L) was evaluated as previously described (8) . Glycated protein (non-CML and CML) levels were measured by competitive immunoassay using purified antibodies specific for total AGEs or CML.
TGF-β1 AND VEGF PRODUCTION ASSAY
To measure TGF-β1 and VEGF production in cell culture supernatants, HPMCs were seeded at 15 × 10 3 cells/ well in 96-well plates for 24 hours, then incubated for a further 24 hours, that is, the same length of time as in the cell proliferation assay with a PDF-culture medium mixture (1/1 ratio).
Production of TGF-β1 was determined using the Quantikine human TGF-β1 immunoassay (R&D Systems, Abingdon, United Kingdom) following the manufacturer's instructions. Production of TGF-β1 in cell culture supernatants was activated by the addition of HCl 1 N for 10 minutes and then neutralized with NaOH 1.2 N/ HEPES 0.5 mol/L. Immediately after activation, samples were incubated in wells coated with TGF-β1 receptor type II. Enzyme-linked antibody specific for TGF-β1 and then substrate solution were added.
Production of VEGF was assessed in cell culture supernatants using the Quantikine human VEGF immunoassay (R&D Systems) according to the manufacturer's instructions. Cell culture supernatants were incubated in wells coated with anti-VEGF 165 and enzyme-linked antibody specific for VEGF was added. Measurement was carried out by the addition of substrate solution.
STATISTICAL ANALYSIS
All experiments were performed with omental HPMCs isolated from different patients. The following were investigated: cell proliferation assay (n = 15), apoptosis and oncosis induction (4000 events recorded per experiment; n = 3), glycated protein formation, and TGF-β1 and VEGF production (n = 6). Results are presented as mean ±standard error of the mean (SEM). Statistical significance was determined using one-way analysis of variance (ANOVA) followed by the parametric Dunnett's test.
RESULTS
PDF-INDUCED INHIBITION OF MESOTHELIAL CELL PROLIFERATION
Proliferation of HPMCs was inhibited by glucose in a concentration-dependent manner for the three different PDFs (Figure 1 ). Compared to the control culture medium, bicaVera PDF containing 15 g/L glucose did not significantly modify cell proliferation. However, when HPMCs were exposed to bicaVera PDF (15 g/L glucose), cell proliferation was significantly higher than when they were exposed to Balance (p < 0.001) or stay·safe PDF (p < 0.001). stay·safe induced the greatest inhibition of [methyl-3 H]thymidine incorporation, which was maximum at a concentration of 42.5 g/L glucose.
PDF-INDUCED APOPTOSIS AND ONCOSIS
Compared to the control culture medium, no significant increase in cell apoptosis and oncosis was induced by bicaVera or Balance (Figure 2) . However, compared 
GLYCATED PROTEIN (NON-CML AND CML) GENERATION AND PDFs
bicaVera (at glucose concentrations of 15 and 42.5 g/L) generated non-CML AGEs to a lesser extent than stay·safe (p < 0.001) or Balance (p < 0.05) (Figure 3) . bicaVera (at concentrations of 15 and 42.5 g/L glucose) generated CML levels that were lower than those formed in stay·safe, and comparable to those formed in control culture medium and in Balance. Generation of CML was correlated with AGE formation, as it was observed that the stay·safe solution induced the highest levels of glycated protein.
STABILITY OF BICAVERA PDF OVER TIME
Stability of bicaVera over time was evaluated by incubating HPMCs with this bicarbonate-buffered PDF at 15 g/L glucose just after (T0), then 12 and 24 months after production (T12 and T24). No differences in proliferation and cell death induction (apoptosis and oncosis) were observed at these time points when cells were exposed to this new-generation PDF. Formation of AGEs (i.e., CML and non-CML) was not affected immediately after production (T0), nor was it affected by storage time of bicaVera (T12 and T24) ( Table 2) .
PDF-INDUCED TGF-β1 AND VEGF PRODUCTION
bicaVera-induced TGF-β1 production was slightly increased compared to Balance at 15 g/L glucose concentration (p < 0.05) (Figure 4) . stay·safe-induced TGF-β1 secretion was higher than that for the other two PDFs. At a concentration of 42.5 g/L glucose, the bicaVera and Balance solutions showed identical results whereas, compared to these, stay·safe PDF induced significantly higher secretion of TGF-β1 (p < 0.01).
Secretion of VEGF was not statistically significantly modified by incubation with bicaVera or Balance (15 g/L glucose) compared to control culture medium. Exposure to bicaVera solution at 15 g/L glucose concentration resulted in lower VEGF levels in HPMC supernatants compared exposure to Balance (p < 0.05) or stay·safe (p < 0.01) PDF. stay·safe PDF at 42.5 g/L glucose concentration induced the highest VEGF levels in HPMC supernatants compared to those for the other two PDFs ( Figure 5 ).
DISCUSSION
Our results confirm the toxic effects of conventional PDFs with high levels of GDPs on mesothelial cell viability, as evidenced by decreased cell proliferation and induction of cell death (apoptosis or oncosis). New-generation PDFs containing lower GDP levels and with a neutral pH, especially the bicarbonate-buffered bicaVera PDF, led to significantly reduced cytotoxicity. Several in vivo and in vitro studies have shown that minimal GDP formation results in better preservation of HPMCs and the mesothelium (8, 12) . Reduction of GDP formation is thus a crucial step in assuring PDF biocompatibility, as there is an as- Human peritoneal mesothelial cell proliferation, apoptosis, and oncosis, and glycated protein formation (total and CML) were measured as described in the Material and Methods section. Experiments were performed using bicaVera at 15 g/L glucose just after production (T0), then 12 and 24 months after production (T12 and T24). Data are expressed mean±SEM. Compared to Balance, HPMC exposure to bicaVera is followed by a higher cell proliferation but lower oncosis induction, AGE formation, and VEGF production. The results of experiments performed using bicaVera may be explained by two mechanisms. First, bicaVera offers a stricter physiological pH (7.4) than Balance (7.0). It is now recognized that there is a protective enzymatic mechanism against glycation. There is a group of enzymes that suppress the physiological levels of potent glycating agents and are instrumental in the repair of glycated proteins: glyoxalase I, aldehyde reductases, and dehydrogenases, amadoriase, and fructosamine 3-phosphokinase (13) . The implication of such enzymatic pathways has not been evaluated during PD but it can be speculated that the closer the abdominal pH is to 7.4, the more optimal the enzymatic activity may be. However, using an in vivo model of PD, it has recently been shown that the improved biocompatibility of bicarbonate/lactate-buffered PDF is not related only to pH (14) . Second, despite a low GDP level in the two biocompatible neutral-pH PD solutions, 3-DG concentration in bicaVera was about 20% lower than in Balance (15 and 42.5 g/L glucose), as shown in Table 1 . AGEs are generated mostly from GDPs and not from glucose per se, which is less reactive (15) . This could, at least in part, explain why bicaVera generated non-CML AGE proteins to a lesser extent than Balance.
Erixon et al. showed that the level of 3,4-DGE was maximal just after heat sterilization of laboratory-made PDF and that it then declined during the first weeks of storage, generating 3-DG, which is less cytotoxic (6) . Because of the lower GDP content in bicaVera compared to the other PDFs studied in this work, assessment of the stability of bicaVera over time was the focus. Evaluation of the stability of bicaVera over time showed comparable viability with respect to conservation, and AGE formation similar to that found immediately after production of this PDF. This corroborates the fact that GDPs -AGE precursors -are essentially generated during heat sterilization and not only following PDF preparation or during the storage period.
Production of TGF-β1 and VEGF was significantly decreased when HPMCs were incubated with new-generation PDFs compared to a conventional PDF. Normalization of TGF-β1 secretion with biocompatible PDFs may limit the fibrosis observed in the peritoneum of long-term PD patients. TGF-β1, which is responsible for the development of fibrosis, is produced by mesothelial cells and is upregulated by AGEs through a RAGE-dependent mechanism. Moreover, blockade of AGE-RAGE interactions in the peritoneum of rats undergoing PD has been found to prevent hyperglycemia-induced peritoneal fibrosis by limiting TGF-β1 expression (16) . VEGF is a potent proangiogenic factor that stimulates microvascular permeability and cell proliferation. It is localized mainly in the mesothelial layer and vessel walls of the peritoneum in PD patients (17) . Certain characteristics of conventional PDFs (i.e., high glucose concentrations, GDPs, and AGEs) can upregulate VEGF expression in mesothelial cells (2, 17, 18) . The increased effective peritoneal surface area is the result of a complex multicellular interaction, and implicates angiogenic factors and vasoactive mediators such as nitric oxide (19) . New-generation PDFs decrease in vitro VEGF production, which suggests that the endothelial area may be reduced in vivo and, consequently, that this could improve the prognosis of patients on longterm PD treatment. Increased glycated protein formation with PDFs high in GDP content, in this instance with stay·safe, is consistent with the low biocompatibility of such PDFs but also with the existence of a correlation between CML-albumin formation and mesothelial cell TGF-β1 and VEGF secretion when exposed to these PDFs (r 2 = 0.62 and r 2 = 0.82, respectively; data not shown).
Human peritoneal mesothelial cells, which constitute the innermost layer of the peritoneum, are a source of a large number of cytokines and growth factors whose production is regulated by various factors, including AGEs. Our in vitro design consisted of a single-cell type co-incubation with various PDFs. This design mimicked the events that occur in mesothelial cells in the peritoneal cavity during dwell time. It did not reflect the complicated multicellular cross-talk involving, among others, endothelial cells and leukocytes, but remains a reliable evaluation of PDF biocompatibility prior to testing in PD patients (20) .
The results of the present in vitro experiments are consistent with those of clinical trials in which it was found that bicarbonate-based PDF allowed recovery of mesothelial cell mass and correction of metabolic acidosis (21, 22) . The use of pure bicarbonate-buffered PDFs also reduced abdominal discomfort (21, 23) .
In conclusion, this study confirms the improved biocompatibility of new-generation two-compartment bag PDFs with neutral pH and lower GDP levels. Although bicaVera displayed a higher level of biocompatibility in terms of mesothelial cell viability and AGE formation, no convincing difference was evidenced in terms of TGF-β1 and VEGF production between the two new-generation PDFs.
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